BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21607795)

  • 1. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy.
    Mizuguchi T; Kawamoto M; Meguro M; Nakamura Y; Harada K; Kukita K; Hirata K
    J Gastrointest Surg; 2011 Aug; 15(8):1433-9. PubMed ID: 21607795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.
    Hiraoka A; Kato M; Marui K; Murakami T; Onishi K; Adachi T; Matsuoka J; Ueki H; Yoshino T; Tsuruta M; Aibiki T; Okudaira T; Kuroda T; Iwasaki R; Suga Y; Miyata H; Ninomiya T; Hirooka M; Abe M; Matsuura B; Michitaka K; Hiasa Y
    Cancer Med; 2021 Jun; 10(11):3584-3592. PubMed ID: 33960691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy.
    Nakamura Y; Mizuguchi T; Kawamoto M; Meguro M; Harada K; Ota S; Hirata K
    Surgery; 2011 Aug; 150(2):250-62. PubMed ID: 21801962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain amino acids to tyrosine ratio (BTR) predicts intrahepatic distant recurrence and survival for early hepatocellular carcinoma.
    Ishikawa T; Kubota T; Horigome R; Kimura N; Honda H; Iwanaga A; Seki K; Honma T; Yoshida T
    Hepatogastroenterology; 2013; 60(128):2055-9. PubMed ID: 24088311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy.
    Kaibori M; Ishizaki M; Matsui K; Nakatake R; Sakaguchi T; Habu D; Yoshiuchi S; Kimura Y; Kon AH
    BMC Gastroenterol; 2013 Jul; 13():119. PubMed ID: 23875788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the molar ratio of branched-chain amino acids to tyrosine before hepatectomy.
    Kohashi T; Itamoto T; Katayama K; Katayama S; Hino H; Nakahara H; Tashiro H; Asahara T
    Hepatogastroenterology; 2002; 49(45):774-7. PubMed ID: 12063988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy.
    Mizuguchi T; Nagayama M; Meguro M; Shibata T; Kaji S; Nobuoka T; Kimura Y; Furuhata T; Hirata K
    J Gastrointest Surg; 2009 Feb; 13(2):325-33. PubMed ID: 18846405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of segmental transcatheter arterial chemoembolization on branched chain amino acids and tyrosine ratio in patients with hepatocellular carcinoma.
    Inoue H; Ito T; Siraki K; Sugimoto K; Sakai T; Oomori S; Takase K; Nakano T
    Int J Oncol; 2000 Nov; 17(5):977-80. PubMed ID: 11029501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2012 May; 18(17):2005-8. PubMed ID: 22563186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients.
    Mizuguchi T; Kawamoto M; Meguro M; Son S; Nakamura Y; Harada K; Shibata T; Ota S; Hirata K
    Hepatogastroenterology; 2012; 59(114):551-7. PubMed ID: 22353523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy.
    Imai K; Beppu T; Yamao T; Okabe H; Hayashi H; Nitta H; Hashimoto D; Mima K; Nakagawa S; Sakamoto K; Chikamoto A; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Nov; 21(12):3817-26. PubMed ID: 24841354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
    Wang ZX; Peng W; Zhang XY; Wen TF; Li C
    Medicine (Baltimore); 2021 Mar; 100(11):e24476. PubMed ID: 33725934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical usefulness of the molar ratio of branched-chain amino acids to tyrosine (BTR) in discriminating stage of chronic liver diseases].
    Sugiyama M; Kanno T; Ohkubo A; Muto Y; Murata K; Ueno Y
    Rinsho Byori; 1992 Jun; 40(6):673-8. PubMed ID: 1513041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios.
    Tada T; Kumada T; Toyoda H; Yasuda S; Koyabu T; Nakashima M
    Nutr Cancer; 2019; 71(7):1132-1141. PubMed ID: 30955354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease.
    Kawamura-Yasui N; Kaito M; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
    J Clin Lab Anal; 1999; 13(1):31-4. PubMed ID: 10025735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.